Jynneos Injection, Powder, Lyophilized, For Suspension
Product Images NDC 50632-024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Jynneos (NDC 50632-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bavarian Nordic A/s, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reconstitution Instructions (Image 01)

Reconstitution Instructions (Image 01)
This is a set of step-by-step instructions on how to reconstitute a lyophilized antigen component called JYNNEOS. The process involves cleansing the vial stoppers, withdrawing the diluent component, transferring it to the lyophilized antigen component vial, shaking gently to dissolve, and then withdrawing the final product for use. It is important to follow each of these steps carefully to ensure proper reconstitution of the antigen.*
FDA Label Image

Jynneos Lyophilized Antigen Component Carton Label (Image 02)

Jynneos Lyophilized Antigen Component Carton Label (Image 02)
This is a description for a lyophilized antigen component used for Smallpox and Monkeypox vaccines. It provides instructions for reconstitution with a diluent component, mentions refrigeration requirements, and indicates that it is prepared from primary chicken embryo fibroblasts with no preservatives. The product may contain trace amounts of gentamicin and ciprofloxacin. Additional information is available in the enclosed prescribing information. The manufacturer is Bavarian Nordic A/S in Denmark. The product is designed for single-dose administration.*
FDA Label Image

Lyophilized Antigen Component Vial Label (Image 03)

Lyophilized Antigen Component Vial Label (Image 03)
This text contains information about a lyophilized antigen labeled as NDC50632-024-04 for use in creating Smallpjsond M’ox Vaccine manufactured by Bavarian Nordic. The reconstituted vaccine, known as JYNNEOS, is administered in a single 0.5 mL dose.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.